The DOI matches its Crossref record.
Abrupt and brief discontinuation of antidepressant treatment: effects on cognitive function and psychomotor performance
Abstract
The abrupt discontinuation of antidepressants can result in a syndrome of adverse events, including somatic, mood and psychomotor reactions. This study examined the effects of discontinuing and resuming antidepressant treatment with four selective serotonin reuptake inhibitors (SSRIs) on cognitive and psychomotor function. Eighty-seven patients receiving maintenance therapy with fluoxetine, sertraline, paroxetine or citalopram had their treatment interrupted for 4-7 days using double-blind placebo. Assessments of aspects of cognitive and psychomotor performance, mood and symptoms were carried out at each visit. Following interruption of treatment, significant differences between the groups emerged. Paroxetine treated patients experienced significantly more cognitive failures (P = 0.007), poorer quality of sleep (P = 0.016), and an increase in depressive symptoms, as rated both subjectively, using the Zung scale (P = 0.006) and by the clinician, using the Montgomery-Asberg Depression Rating Scale (P = 0.0003) and Clinical Global Impression (P = 0.0003), compared to some or all of the other drugs. All changes were reversed on reinstatement of treatment. Abrupt discontinuation of treatment with paroxetine leads to deterioration in various aspects of health and functioning, which may be related to the antidepressant discontinuation syndrome. These effects are not evident in patients receiving fluoxetine, sertraline and citalopram, suggesting they are not an SSRI class phenomenon.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Medications with shorter half-lives, like paroxetine, produce withdrawal symptoms with greater incidence 5,[15][16][17][18] , quicker onset 5,[15][16][17][18] , and greater severity 5,[15][16][17][18] than medications with longer half-lives, like fluoxetine 5,15,17,18 .”
From Tapering of SSRI treatment to mitigate withdrawal symptoms (2019) · cites this paper as [17]
In the citing paper
“SSRI withdrawal symptoms occur in many patients, with reported incidence rates varying from 42-100% for paroxetine 5,[15][16][17][18] , to 9-77% for fluoxetine 5,15,17,18 , and median rates of 53.6% for SSRIs across 14 studies that examined antidepressant withdrawal 13 .”
From Tapering of SSRI treatment to mitigate withdrawal symptoms (2019) · cites this paper as [17]
In the citing paper
“This shift was heavily supported by the pharmaceutical industry [27,88] and was aimed at emphasizing that SSRI do not cause addiction or dependence, and symptoms are substantially different from the phenomena that take place with benzodiazepines [24] .”
From Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review (2015) · cites this paper as [24]
Citations
Cites
Still being checked.
Cited by
Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436
Davies, J., & Read, J. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.08.027 · Cited by 387
The Physiological Role of 5-HT2AReceptors in Working Memory
Williams, G. V., Rao, S. G., & Goldman-Rakic, P. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02843.2002 · Cited by 311
Citalopram versus other anti-depressive agents for depression
Cipriani, A., Purgato, M., Furukawa, T. A., Trespidi, C., Imperadore, G., Signoretti, A., Churchill, R., Watanabe, N., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006534.pub2 · Cited by 311
Antidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286
Metadata
- Authors
- Hindmarch, I., Kimber, S., & Cockle, S. M.
- Affiliations
- University of Surrey (GB)
- Corresponding author
- Cockle, S. M.
- ORCID
- Kimber, S.
- Venue
- International Clinical Psychopharmacology
- Published
- 2000-11
- Volume
- 15
- Issue
- 6
- Pages
- 305-318
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2026134394
- Cited by
- 84
- References
- 0
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 3 · 2019: 4 · 2018: 3 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 5 · 2012: 3
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- antidepressant discontinuation syndrome, selective serotonin reuptake inhibitors, paroxetine, fluoxetine, sertraline, citalopram, cognitive function, psychomotor performance, sleep quality, depressive symptoms
- MeSH terms
- Adult, Cognition, Depressive Disorder, Female, Flicker Fusion, Humans, Male, Psychiatric Status Rating Scales, Psychomotor Performance, Reaction Time, Sleep, Substance Withdrawal Syndrome, Antidepressive Agents, Second-Generation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Abrupt and brief discontinuation of antidepressant treatment: effects on cognitive function and psychomotor performance. https://app.cochat.ai/papers/10.1097/00004850-200015060-00001
- The paper
- Hindmarch, I., Kimber, S., & Cockle, S. M. (2000). Abrupt and brief discontinuation of antidepressant treatment: effects on cognitive function and psychomotor performance. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-200015060-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.